ArticlePloS one2013

Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson's disease.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.